21CEC PX PHARM LTD

Company Registration Number:
04784475 (England and Wales)

Unaudited micro entity accounts for the year ended 05 April 2024

Period of accounts

Start date: 06 April 2023

End date: 05 April 2024

21CEC PX PHARM LTD

Contents of the Financial Statements

for the Period Ended 05 April 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

21CEC PX PHARM LTD

Company Information

for the Period Ended 05 April 2024




Director: Claire Chan Bleasdale
Registered office: 45
Oaklands
Westham
Pevensey
BN24 5AW
Company Registration Number: 04784475 (England and Wales)

21CEC PX PHARM LTD

Directors' Report Period Ended 05 April 2024

The directors present their report with the financial statements of the company for the period ended 05 April 2024

Principal Activities

We had to reduce all expenses as possible. Due to the Russia-Ukraine war, Middle East war, and high inflation, the research market is very poor, and we can only waiting for the global situation change.

Directors

The director(s) shown below were appointed to the company during the period
Claire Chan Bleasdale
06 April 2023

This report was approved by the board of directors on 29 October 2024
And Signed On Behalf Of The Board By:

Name: Claire Chan Bleasdale
Status: Director

21CEC PX PHARM LTD

Profit and Loss Account

for the Period Ended 05 April 2024


2024
£

2023
£
Turnover 1,135 10,750
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 525 ) ( 5,963 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Profit or (Loss) for Period 610 4,787

21CEC PX PHARM LTD

Balance sheet

As at 05 April 2024


2024
£

2023
£
Fixed Assets: 2,114 2,114
Current assets: 11,557 22,774
Net current assets (liabilities): 11,557 22,774
Total assets less current liabilities: 13,671 24,888
Total net assets (liabilities): 13,671 24,888
Capital and reserves: 13,671 24,888

21CEC PX PHARM LTD

Balance sheet continued

For the year ending 5 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 October 2024
And Signed On Behalf Of The Board By:

Name: Claire Chan Bleasdale
Status: Director

The notes form part of these financial statements

21CEC PX PHARM LTD

Footnotes to the Financial Statements

for the Period Ended 05 April 2024

  • 1. Employee Information

    Average number of employees: 2

21CEC PX PHARM LTD

Footnotes to the Financial Statements

for the Period Ended 05 April 2024

  • 2. Off balance sheet disclosure

    No